Oncotelic Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-24.7M |
| Depreciation & Amortization | — |
| Depreciation | $123.0K |
| Amortization | — |
| Stock-Based Compensation | $530.0K |
| Net Cash from Operating Activities | $-28.7M |
| Investing Activities | |
| Capital Expenditures | $109.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $2.9M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $21.4M |
| Net Change in Cash | $-4.3M |
| Free Cash Flow | $-28.8M |